These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Neurofibromatosis type 1 and optic pathway gliomas: follow-up of 54 patients. Thiagalingam S; Flaherty M; Billson F; North K Ophthalmology; 2004 Mar; 111(3):568-77. PubMed ID: 15019338 [TBL] [Abstract][Full Text] [Related]
3. Natural history and outcome of optic pathway gliomas in children. Nicolin G; Parkin P; Mabbott D; Hargrave D; Bartels U; Tabori U; Rutka J; Buncic JR; Bouffet E Pediatr Blood Cancer; 2009 Dec; 53(7):1231-7. PubMed ID: 19621457 [TBL] [Abstract][Full Text] [Related]
4. Second neoplasms after megavoltage radiation for pediatric tumors. Gold DG; Neglia JP; Dusenbery KE Cancer; 2003 May; 97(10):2588-96. PubMed ID: 12733158 [TBL] [Abstract][Full Text] [Related]
5. [Neurofibromatosis type 1 and optic pathway gliomas. A series of 80 patients]. Pascual-Castroviejo I; Pascual-Pascual SI; Velázquez-Fragua R; Viaño J; García-Segura JM; Botella MP Rev Neurol; 2008 May 1-15; 46(9):530-6. PubMed ID: 18446694 [TBL] [Abstract][Full Text] [Related]
6. Follow-up of optic pathway gliomas in children with neurofibromatosis type 1. Kuenzle C; Weissert M; Roulet E; Bode H; Schefer S; Huisman T; Landau K; Boltshauser E Neuropediatrics; 1994 Dec; 25(6):295-300. PubMed ID: 7770126 [TBL] [Abstract][Full Text] [Related]
7. Extensive central nervous system involvement in optic pathway gliomas in neurofibromatosis type 1. Shaikh F; Johnston D; Michaud J; Hurteau J; Vassilyadi M; Keene D Pediatr Blood Cancer; 2011 Oct; 57(4):688-6690. PubMed ID: 21465640 [TBL] [Abstract][Full Text] [Related]
8. Screening and diagnosis of optic pathway gliomas in children with neurofibromatosis type 1 by using sweep visual evoked potentials. Chang BC; Mirabella G; Yagev R; Banh M; Mezer E; Parkin PC; Westall CA; Buncic JR Invest Ophthalmol Vis Sci; 2007 Jun; 48(6):2895-902. PubMed ID: 17525226 [TBL] [Abstract][Full Text] [Related]
9. Neurofibromatosis type 1 and optic pathway glioma. A long-term follow-up. Lama G; Esposito Salsano M; Grassia C; Calabrese E; Grassia MG; Bismuto R; Melone MA; Russo S; Scuotto A Minerva Pediatr; 2007 Feb; 59(1):13-21. PubMed ID: 17301720 [TBL] [Abstract][Full Text] [Related]
10. The risk of second primary tumors in patients with nasopharyngeal carcinoma after definitive radiotherapy. Kong L; Lu JJ; Hu C; Guo X; Wu Y; Zhang Y Cancer; 2006 Sep; 107(6):1287-93. PubMed ID: 16909425 [TBL] [Abstract][Full Text] [Related]
11. Second tumors in pediatric patients treated with radiotherapy to the central nervous system. Galloway TJ; Indelicato DJ; Amdur RJ; Swanson EL; Smith AA; Marcus RB Am J Clin Oncol; 2012 Jun; 35(3):279-83. PubMed ID: 21383606 [TBL] [Abstract][Full Text] [Related]
12. A molecular analysis of individuals with neurofibromatosis type 1 (NF1) and optic pathway gliomas (OPGs), and an assessment of genotype-phenotype correlations. Sharif S; Upadhyaya M; Ferner R; Majounie E; Shenton A; Baser M; Thakker N; Evans DG J Med Genet; 2011 Apr; 48(4):256-60. PubMed ID: 21278392 [TBL] [Abstract][Full Text] [Related]
13. Optic pathway gliomas in patients with neurofibromatosis type 1: follow-up of 44 patients. Segal L; Darvish-Zargar M; Dilenge ME; Ortenberg J; Polomeno RC J AAPOS; 2010 Apr; 14(2):155-8. PubMed ID: 20451859 [TBL] [Abstract][Full Text] [Related]
14. Second neoplasms in pediatric patients with primary central nervous system tumors: the St. Jude Children's Research Hospital experience. Broniscer A; Ke W; Fuller CE; Wu J; Gajjar A; Kun LE Cancer; 2004 May; 100(10):2246-52. PubMed ID: 15139071 [TBL] [Abstract][Full Text] [Related]
15. [Cerebral tumors in children with neurofibromatosis type 1]. Micheli R; Giordano L; Balestrini MR Minerva Pediatr; 1996 Mar; 48(3):89-97. PubMed ID: 8766674 [TBL] [Abstract][Full Text] [Related]
16. Nonperioperative strokes in children with central nervous system tumors. Bowers DC; Mulne AF; Reisch JS; Elterman RD; Munoz L; Booth T; Shapiro K; Doxey DL Cancer; 2002 Feb; 94(4):1094-101. PubMed ID: 11920480 [TBL] [Abstract][Full Text] [Related]
17. Moyamoya following cranial irradiation for primary brain tumors in children. Ullrich NJ; Robertson R; Kinnamon DD; Scott RM; Kieran MW; Turner CD; Chi SN; Goumnerova L; Proctor M; Tarbell NJ; Marcus KJ; Pomeroy SL Neurology; 2007 Mar; 68(12):932-8. PubMed ID: 17372129 [TBL] [Abstract][Full Text] [Related]
18. [Long-term outcome of gliomas of the visual pathway in type 1 neurofibromatosis]. Schröder S; Baumann-Schröder U; Hazim W; Haase W; Mautner VF Klin Monbl Augenheilkd; 1999 Dec; 215(6):349-54. PubMed ID: 10637799 [TBL] [Abstract][Full Text] [Related]
19. Visual outcome of a cohort of children with neurofibromatosis type 1 and optic pathway glioma followed by a pediatric neuro-oncology program. Dalla Via P; Opocher E; Pinello ML; Calderone M; Viscardi E; Clementi M; Battistella PA; Laverda AM; Da Dalt L; Perilongo G Neuro Oncol; 2007 Oct; 9(4):430-7. PubMed ID: 17704361 [TBL] [Abstract][Full Text] [Related]
20. Secondary neoplasms after radiotherapy for a childhood solid tumor. Paulino AC; Fowler BZ Pediatr Hematol Oncol; 2005 Mar; 22(2):89-101. PubMed ID: 15804994 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]